Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acupuncture Therapy | 6 | 2024 | 93 | 0.720 |
Why?
|
| Xerostomia | 5 | 2024 | 201 | 0.620 |
Why?
|
| Pain, Intractable | 3 | 2000 | 171 | 0.380 |
Why?
|
| Electroacupuncture | 3 | 2014 | 35 | 0.330 |
Why?
|
| Radiation Injuries | 3 | 2024 | 1449 | 0.300 |
Why?
|
| Pain | 4 | 2012 | 1693 | 0.190 |
Why?
|
| Nasopharyngeal Neoplasms | 3 | 2012 | 325 | 0.180 |
Why?
|
| Head and Neck Neoplasms | 3 | 2024 | 4065 | 0.170 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2014 | 399 | 0.150 |
Why?
|
| Psoas Muscles | 1 | 1996 | 12 | 0.140 |
Why?
|
| Muscle Neoplasms | 1 | 1996 | 109 | 0.120 |
Why?
|
| Pain, Postoperative | 2 | 2010 | 647 | 0.120 |
Why?
|
| Nerve Block | 1 | 1996 | 185 | 0.110 |
Why?
|
| Liposarcoma | 1 | 1996 | 244 | 0.110 |
Why?
|
| Antiemetics | 1 | 2014 | 124 | 0.110 |
Why?
|
| Pelvic Neoplasms | 1 | 1995 | 203 | 0.110 |
Why?
|
| Radiotherapy | 3 | 2024 | 1852 | 0.110 |
Why?
|
| Vomiting | 1 | 2014 | 360 | 0.110 |
Why?
|
| Nausea | 1 | 2014 | 536 | 0.100 |
Why?
|
| Peripheral Nerves | 1 | 2012 | 162 | 0.100 |
Why?
|
| Diabetic Neuropathies | 1 | 2012 | 102 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 229 | 0.090 |
Why?
|
| Multiple Myeloma | 2 | 2014 | 2237 | 0.090 |
Why?
|
| Ileus | 1 | 2010 | 31 | 0.090 |
Why?
|
| Indoles | 1 | 2014 | 1029 | 0.080 |
Why?
|
| Isoflurane | 1 | 2009 | 68 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 62 | 0.080 |
Why?
|
| Colectomy | 1 | 2010 | 292 | 0.080 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 210 | 0.070 |
Why?
|
| Tongue Neoplasms | 1 | 2009 | 253 | 0.070 |
Why?
|
| Quality of Life | 6 | 2024 | 4724 | 0.070 |
Why?
|
| Skin | 1 | 2012 | 1281 | 0.070 |
Why?
|
| Analgesics, Opioid | 3 | 2000 | 1425 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 1422 | 0.050 |
Why?
|
| omega-Conotoxins | 1 | 2000 | 7 | 0.050 |
Why?
|
| Adrenal Medulla | 1 | 2000 | 17 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2000 | 44 | 0.040 |
Why?
|
| Butyrylcholinesterase | 1 | 1999 | 5 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2000 | 81 | 0.040 |
Why?
|
| Boronic Acids | 2 | 2014 | 364 | 0.040 |
Why?
|
| Bortezomib | 2 | 2014 | 549 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2000 | 177 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 14521 | 0.040 |
Why?
|
| Pyrazines | 2 | 2014 | 507 | 0.040 |
Why?
|
| Fentanyl | 1 | 2000 | 154 | 0.040 |
Why?
|
| Thalidomide | 2 | 2014 | 577 | 0.040 |
Why?
|
| Middle Aged | 8 | 2024 | 89359 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2024 | 34263 | 0.040 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1998 | 62 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2000 | 263 | 0.040 |
Why?
|
| Humans | 16 | 2024 | 270194 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2014 | 2361 | 0.040 |
Why?
|
| Analgesia, Epidural | 1 | 1998 | 105 | 0.030 |
Why?
|
| Male | 9 | 2024 | 127386 | 0.030 |
Why?
|
| Female | 10 | 2024 | 147100 | 0.030 |
Why?
|
| Adult | 7 | 2019 | 80647 | 0.030 |
Why?
|
| Acupuncture Points | 1 | 2014 | 18 | 0.030 |
Why?
|
| Heel | 1 | 2014 | 11 | 0.030 |
Why?
|
| Leg | 1 | 1996 | 232 | 0.030 |
Why?
|
| Neoplasms | 2 | 1998 | 15685 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1995 | 251 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1998 | 499 | 0.030 |
Why?
|
| Aged | 5 | 2024 | 72779 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 5494 | 0.030 |
Why?
|
| Medical Records | 1 | 1995 | 427 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 9010 | 0.030 |
Why?
|
| Streptozocin | 1 | 2012 | 73 | 0.030 |
Why?
|
| Salivation | 1 | 2012 | 22 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 1999 | 3149 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 16287 | 0.020 |
Why?
|
| Organoplatinum Compounds | 1 | 2014 | 705 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2012 | 224 | 0.020 |
Why?
|
| Anxiety | 1 | 1998 | 1248 | 0.020 |
Why?
|
| Carcinoma | 2 | 2012 | 2596 | 0.020 |
Why?
|
| Defecation | 1 | 2010 | 59 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2014 | 1001 | 0.020 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2010 | 47 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 2010 | 94 | 0.020 |
Why?
|
| Hypoventilation | 1 | 2009 | 13 | 0.020 |
Why?
|
| Hyperventilation | 1 | 2009 | 19 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2009 | 57 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2009 | 194 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2010 | 135 | 0.020 |
Why?
|
| Time Factors | 2 | 2014 | 13256 | 0.020 |
Why?
|
| Inflammation | 1 | 1998 | 2563 | 0.020 |
Why?
|
| Depression | 1 | 1998 | 1765 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 2121 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 22201 | 0.020 |
Why?
|
| Cisplatin | 1 | 2014 | 2466 | 0.020 |
Why?
|
| Respiration | 1 | 2009 | 450 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2010 | 1431 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 728 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 6217 | 0.010 |
Why?
|
| Palliative Care | 1 | 1995 | 2134 | 0.010 |
Why?
|
| Pain Management | 1 | 2009 | 704 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 2870 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2009 | 3976 | 0.010 |
Why?
|
| Succinylcholine | 1 | 1999 | 6 | 0.010 |
Why?
|
| Apnea | 1 | 1999 | 33 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1996 | 7967 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1995 | 7747 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1998 | 58 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 1998 | 267 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 4769 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1998 | 201 | 0.010 |
Why?
|
| Analgesia | 1 | 1998 | 95 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 5934 | 0.010 |
Why?
|
| Child | 1 | 1998 | 30264 | 0.010 |
Why?
|
| Animals | 2 | 2012 | 60992 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1999 | 511 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 13305 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1999 | 695 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 1998 | 683 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 5017 | 0.010 |
Why?
|
| Patient Selection | 1 | 1998 | 2109 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1999 | 16816 | 0.000 |
Why?
|